DK1892298T3 - Streptokok C5a-peptidase-vaccine - Google Patents

Streptokok C5a-peptidase-vaccine

Info

Publication number: DK1892298T3
Authority: DK; Denmark
Prior art keywords: streptococcal; scp; disclosed; infection; peptidase
Prior art date: 1998-12-07

Application number

DK07015995.9T

Other languages

English (en)

Inventor

Paul Patrick Cleary

Deborah K Stafslien

Original Assignee

Univ Minnesota

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-12-07

Filing date

1999-12-03

Publication date

2011-06-14

1999-12-03 Application filed by Univ Minnesota filed Critical Univ Minnesota

2011-06-14 Application granted granted Critical

2011-06-14 Publication of DK1892298T3 publication Critical patent/DK1892298T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21043—Classical-complement-pathway C3/C5 convertase (3.4.21.43)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/823—Bacterial vaccine for bovine species, e.g. cattle
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/825—Bacterial vaccine for porcine species, e.g. swine
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/828—Bacterial vaccine for canidae or mustelidae, e.g. dogs, foxes, minks
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/829—Bacterial vaccine for equine species, e.g. horses
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/831—Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/825—Bacteria

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Microbiology (AREA)
Biomedical Technology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biochemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Immunology (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Mycology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Enzymes And Modification Thereof (AREA)
Exposure Control For Cameras (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK07015995.9T 1998-12-07 1999-12-03 Streptokok C5a-peptidase-vaccine DK1892298T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US09/206,898 US6355255B1 (en)	1998-12-07	1998-12-07	Streptococcal C5a peptidase vaccine
EP99966013A EP1137785B8 (en)	1998-12-07	1999-12-03	STREPTOCOCCAL C5a PEPTIDASE VACCINE

Publications (1)

Publication Number	Publication Date
DK1892298T3 true DK1892298T3 (da)	2011-06-14

Family

ID=43662233

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
DK07015995.9T DK1892298T3 (da)	1998-12-07	1999-12-03	Streptokok C5a-peptidase-vaccine
DK10185549.2T DK2308981T3 (da)	1998-12-07	1999-12-03	Streptokok-C5a-peptidase-vaccine
DK99966013T DK1137785T3 (da)	1998-12-07	1999-12-03	Streptokok-C5a-peptidasevaccine

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
DK10185549.2T DK2308981T3 (da)	1998-12-07	1999-12-03	Streptokok-C5a-peptidase-vaccine
DK99966013T DK1137785T3 (da)	1998-12-07	1999-12-03	Streptokok-C5a-peptidasevaccine

Country Status (18)

Country	Link
US (4)	US6355255B1 (da)
EP (3)	EP1892298B1 (da)
JP (2)	JP5122703B2 (da)
KR (1)	KR100777502B1 (da)
CN (2)	CN1679929B (da)
AT (2)	ATE503017T1 (da)
AU (2)	AU779085B2 (da)
BR (1)	BRPI9915988B8 (da)
CA (1)	CA2354508C (da)
CY (1)	CY1106983T1 (da)
DE (2)	DE69943305D1 (da)
DK (3)	DK1892298T3 (da)
ES (3)	ES2401998T3 (da)
IL (2)	IL143289A0 (da)
MX (1)	MXPA01005757A (da)
PT (3)	PT1892298E (da)
SI (2)	SI1892298T1 (da)
WO (1)	WO2000034487A1 (da)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6355255B1 (en) *	1998-12-07	2002-03-12	Regents Of The University Of Minnesota	Streptococcal C5a peptidase vaccine
US6824997B1 (en) *	1998-09-18	2004-11-30	Binax, Inc.	Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies
US9134303B1 (en)	1998-08-25	2015-09-15	Alere Scarborough, Inc.	ICT immunoassay for Legionella pneumophila serogroup 1 antigen employing affinity purified antibodies thereto
US7256265B2 (en) *	1999-12-03	2007-08-14	Regents Of The University Of Minnesota	Streptococcal C5a peptidase vaccine
CA2425303A1 (en) *	2000-10-27	2002-05-02	John Telford	Nucleic acids and proteins from streptococcus groups a & b
MX339524B (es)	2001-10-11	2016-05-30	Wyeth Corp	Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
US7785608B2 (en) *	2002-08-30	2010-08-31	Wyeth Holdings Corporation	Immunogenic compositions for the prevention and treatment of meningococcal disease
US7301554B2 (en) *	2002-09-20	2007-11-27	Ricoh Company, Ltd.	Light scanning device, scanning line adjusting method, scanning line adjusting control method, image forming apparatus, and image forming method
CA2523358A1 (en) *	2003-04-23	2004-11-04	Hansa Medical Ab	Method for identifying an anti-streptococcal agent and its use for treating streptococcal infections
AU2005302269B2 (en)	2004-11-01	2011-05-19	The Brigham And Women's Hospital, Inc.	Modified streptococcal polysaccharides and uses thereof
GB2428006A (en) *	2005-07-07	2007-01-17	Jevgenis Morov	AMI-3 vaccine comprising group A Streptococcus pyogenes bacteria
US7596254B2 (en) *	2006-03-17	2009-09-29	William Marsh Rice University	Intra-operative 3-D reconstruction of bone cement boli using X-rays
TW200806315A (en)	2006-04-26	2008-02-01	Wyeth Corp	Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
JP5785686B2 (ja) *	2006-06-23	2015-09-30	ダニスコ・ユーエス・インク、ジェネンコー・ディビジョン	複数の性質をエンジニアリングするための部位評価ライブラリーを用いた、配列と活性との関係の系統的な評価
US20080311129A1 (en) *	2006-11-02	2008-12-18	Camas Incorporated	Adherence inhibitor directed to and method of making and using
AR064642A1 (es)	2006-12-22	2009-04-15	Wyeth Corp	Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
WO2008127179A1 (en) *	2007-04-16	2008-10-23	Lunds Universitets Utvecklingsaktiebolag	Fusion protein vaccine
AU2008299376B2 (en)	2007-09-12	2013-02-28	Glaxosmithkline Biologicals S.A.	GAS57 mutant antigens and GAS57 antibodies
US8563001B2 (en) *	2008-11-05	2013-10-22	Regents Of The University Of Minnesota	Multicomponent immunogenic composition for the prevention of beta-hemolytic streptococcal (BHS) disease
SI2575870T1 (sl)	2010-06-04	2017-01-31	Wyeth Llc	Formulacije cepiva
DK3246044T4 (da)	2010-08-23	2024-05-21	Wyeth Llc	Stabile formuleringer af Neisseria-meningitidis-RLP2086-antigener
PE20140173A1 (es)	2010-09-10	2014-02-20	Wyeth Llc	Variantes no lipidadas de antigenos orf2086 de neisseria meningitidis
ITMI20111182A1 (it)	2011-06-28	2012-12-29	Canio Buonavoglia	Vaccino per coronavirus canino
CA2865745C (en)	2012-03-09	2018-01-09	Pfizer Inc.	Neisseria meningitidis compositions and methods thereof
SA115360586B1 (ar)	2012-03-09	2017-04-12	فايزر انك	تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
CN102746388B (zh) *	2012-07-02	2014-06-25	中山大学	一种链球菌保护性抗原C5a及其制备方法
JP6446377B2 (ja)	2013-03-08	2018-12-26	ファイザー・インク	免疫原性融合ポリペプチド
MX369534B (es)	2013-09-08	2019-11-11	Pfizer	Composiciones de neisseria meningitidis y sus metodos.
US10888611B2 (en)	2015-02-19	2021-01-12	Pfizer Inc.	Neisseria meningitidis compositions and methods thereof
US10183070B2 (en)	2017-01-31	2019-01-22	Pfizer Inc.	Neisseria meningitidis compositions and methods thereof
CN106822885B (zh) *	2017-02-16	2020-06-30	清华大学	肺炎链球菌疫苗
WO2018175783A1 (en) *	2017-03-22	2018-09-27	Modernatx, Inc.	Rna bacterial vaccines
CN109045292A (zh) *	2018-11-08	2018-12-21	山东大学	一种a群链球菌寡糖蛋白缀合物及其制备方法与应用
WO2021059181A1 (en)	2019-09-27	2021-04-01	Pfizer Inc.	Neisseria meningitidis compositions and methods thereof
JP2023514332A (ja) *	2020-02-18	2023-04-05	バックスサイト・インコーポレイテッド	多糖－タンパク質コンジュゲートを含むａ群ｓｔｒｅｐ免疫原性組成物
KR102165688B1 (ko)	2020-04-03	2020-10-14	주식회사 퀀타매트릭스	그람 양성균 배양용 배양액
US20230035004A1 (en) *	2021-07-28	2023-02-02	Nutech Ventures	Therapeutic compositions containing bacterial outer membrane vesicles and uses thereof
KR20240128715A (ko)	2022-01-13	2024-08-26	화이자 인코포레이티드	접합된 피막 사카라이드 항원을 포함하는 면역원성 조성물 및 그의 용도
WO2024110827A1 (en)	2022-11-21	2024-05-30	Pfizer Inc.	Methods for preparing conjugated capsular saccharide antigens and uses thereof
CN120265317A (zh)	2022-11-22	2025-07-04	辉瑞公司	包含经缀合的荚膜糖抗原的免疫原性组合物及其用途
EP4661911A1 (en)	2023-02-10	2025-12-17	Pfizer Inc.	Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
AU2024246082A1 (en)	2023-03-30	2025-10-16	Pfizer Inc.	Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
AU2024255922A1 (en)	2023-04-14	2025-10-30	Pfizer Inc.	Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
WO2024224266A1 (en)	2023-04-24	2024-10-31	Pfizer Inc.	Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
WO2025057078A1 (en)	2023-09-14	2025-03-20	Pfizer Inc.	Adjuvanted immunogenic compositions comprising conjugated pneumococcal capsular saccharide antigens and uses thereof
WO2025133971A1 (en)	2023-12-23	2025-06-26	Pfizer Inc.	Improved methods for producing bacterial capsular saccharide glycoconjugates
WO2025186705A2 (en)	2024-03-06	2025-09-12	Pfizer Inc.	Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
WO2025191415A1 (en)	2024-03-11	2025-09-18	Pfizer Inc.	Immunogenic compositions comprising conjugated escherichia coli saccharides and uses thereof
WO2025219908A2 (en)	2024-04-19	2025-10-23	Pfizer Inc.	Media and fermentation methods for polysaccharide production in bacterial cell culture
WO2025219904A1 (en)	2024-04-19	2025-10-23	Pfizer Inc.	Improved methods for producing glycoconjugates by reductive amination in aprotic solvent

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4152411A (en) *	1977-07-27	1979-05-01	Akzona Incorporated	High specific activity labeled substances
DE2964721D1 (en)	1978-08-24	1983-03-17	Nat Res Dev	Pasteurellosis vaccines
US5077044A (en) *	1980-05-19	1991-12-31	The Board Of Trustees Of The Leland Stanford Jr. University	Novel non-reverting shigella live vaccines
US4454121A (en)	1982-07-27	1984-06-12	The University Of Tennessee Research Corporation	Synthetic peptides corresponding to antigenic determinants of the M protein of Streptococcus pyogenes
US4695562A (en)	1984-04-06	1987-09-22	Univ. Of Tennessee Research Corp.	Synthetic peptide compounds
US4772584A (en)	1986-05-23	1988-09-20	Cleary Paul P	Inhibitor of C5a-mediated chemotaxis
EP0272929B1 (en)	1986-12-24	1996-03-20	Genentech, Inc.	Enkephalinase for therapeutic use
US5162226A (en)	1987-08-24	1992-11-10	University Of Tennessee Research Corp. (U.T.R.C.)	Therapeutic compositions against streptococcal infections, transformed hosts, methods of immunization and genetically engineered products
US5124153A (en)	1987-08-24	1992-06-23	University Of Tennessee Research Corp.	Therapeutic compositions against streptococcal infections, transformed hosts, methods of immunization and genetically engineered products
AU630093B2 (en)	1988-03-25	1992-10-22	Rockefeller University, The	Synthetic peptides from streptococcal m protein and vaccines prepared therefrom
US4863159A (en)	1988-03-25	1989-09-05	Morrison Molded Fiber Glass Company	Apparatus for use in the exercise of the human body
AU645344B2 (en)	1990-07-31	1994-01-13	Genentech Inc.	Tissue plasminogen activator variants with decreased clearance
US6100380A (en) *	1991-10-28	2000-08-08	Cytran, Inc.	Immunomodulating peptides and methods of use
AU668908B2 (en)	1992-01-08	1996-05-23	Rockefeller University, The	Multifunctional surface protein of streptococci
AU668714B2 (en)	1992-03-09	1996-05-16	Novo Nordisk A/S	Compositions and methods for the identification and synthesis of sialyltransferases
WO1993021220A1 (en)	1992-04-08	1993-10-28	The Council Of The Queensland Institute Of Medical Research	Synthetic peptides useful in a vaccine against and in the diagnosis of streptococcal infection
IL106922A (en)	1992-09-14	1998-08-16	Novartis Ag	Composite materials with one or more wettable surfaces and process for their preparation
DK0618813T3 (da)	1992-09-16	2002-03-11	Univ Tennessee Res Corp	Antigen for M-hybridprotein og bærer for gruppe A streptococcal vaccine
DK0625043T3 (da)	1992-09-16	2002-04-22	Univ Tennessee Res Corp	Vaccine med rekombinant multivalent M-protein
US5866135A (en)	1994-04-21	1999-02-02	North American Vaccine, Inc.	Group A streptococcal polysaccharide immunogenic compositions and methods
US5679654A (en)	1994-09-02	1997-10-21	Brigham & Women's Hospital, Inc.	Capsular polysaccharide immunomodulator
US5618129A (en)	1995-03-13	1997-04-08	Paragon Electric Company, Inc.	Snap-engaging mounting plate
US5846547A (en) *	1996-01-22	1998-12-08	Regents Of The University Of Minnesota	Streptococcal C5a peptidase vaccine
US6355255B1 (en)	1998-12-07	2002-03-12	Regents Of The University Of Minnesota	Streptococcal C5a peptidase vaccine
US7256265B2 (en)	1999-12-03	2007-08-14	Regents Of The University Of Minnesota	Streptococcal C5a peptidase vaccine
US6605302B2 (en) *	2001-07-17	2003-08-12	Osmotica Corp.	Drug delivery device containing oseltamivir and an H1 antagonist

1998
- 1998-12-07 US US09/206,898 patent/US6355255B1/en not_active Expired - Lifetime
1999
- 1999-12-03 SI SI9931054T patent/SI1892298T1/sl unknown
- 1999-12-03 DK DK07015995.9T patent/DK1892298T3/da active
- 1999-12-03 PT PT07015995T patent/PT1892298E/pt unknown
- 1999-12-03 PT PT101855492T patent/PT2308981E/pt unknown
- 1999-12-03 CN CN2005100529270A patent/CN1679929B/zh not_active Expired - Lifetime
- 1999-12-03 MX MXPA01005757A patent/MXPA01005757A/es active IP Right Grant
- 1999-12-03 IL IL14328999A patent/IL143289A0/xx unknown
- 1999-12-03 EP EP07015995A patent/EP1892298B1/en not_active Expired - Lifetime
- 1999-12-03 SI SI9931070T patent/SI2308981T1/sl unknown
- 1999-12-03 KR KR1020017007021A patent/KR100777502B1/ko not_active Expired - Lifetime
- 1999-12-03 EP EP10185549A patent/EP2308981B1/en not_active Expired - Lifetime
- 1999-12-03 AT AT07015995T patent/ATE503017T1/de active
- 1999-12-03 ES ES10185549T patent/ES2401998T3/es not_active Expired - Lifetime
- 1999-12-03 DK DK10185549.2T patent/DK2308981T3/da active
- 1999-12-03 WO PCT/US1999/028826 patent/WO2000034487A1/en not_active Ceased
- 1999-12-03 BR BRPI9915988A patent/BRPI9915988B8/pt not_active IP Right Cessation
- 1999-12-03 ES ES07015995T patent/ES2363446T3/es not_active Expired - Lifetime
- 1999-12-03 DE DE69943305T patent/DE69943305D1/de not_active Expired - Lifetime
- 1999-12-03 EP EP99966013A patent/EP1137785B8/en not_active Expired - Lifetime
- 1999-12-03 AU AU21665/00A patent/AU779085B2/en not_active Expired
- 1999-12-03 DE DE69936877T patent/DE69936877T2/de not_active Expired - Lifetime
- 1999-12-03 ES ES99966013T patent/ES2293745T3/es not_active Expired - Lifetime
- 1999-12-03 JP JP2000586920A patent/JP5122703B2/ja not_active Expired - Lifetime
- 1999-12-03 AT AT99966013T patent/ATE370237T1/de active
- 1999-12-03 CN CNB998141925A patent/CN100389198C/zh not_active Expired - Lifetime
- 1999-12-03 PT PT99966013T patent/PT1137785E/pt unknown
- 1999-12-03 DK DK99966013T patent/DK1137785T3/da active
- 1999-12-03 CA CA2354508A patent/CA2354508C/en not_active Expired - Lifetime
2001
- 2001-05-22 IL IL143289A patent/IL143289A/en not_active IP Right Cessation
- 2001-05-30 US US09/870,122 patent/US6951653B2/en not_active Expired - Fee Related
2004
- 2004-08-10 US US10/915,705 patent/US7635483B2/en not_active Expired - Fee Related
- 2004-11-16 AU AU2004231164A patent/AU2004231164B2/en not_active Ceased
2005
- 2005-03-03 US US11/071,041 patent/US8440205B2/en not_active Expired - Fee Related
2007
- 2007-11-08 CY CY20071101432T patent/CY1106983T1/el unknown
2011
- 2011-10-28 JP JP2011237153A patent/JP2012072153A/ja active Pending

Also Published As

Publication number	Publication date
CN1679929A (zh)	2005-10-12
AU2004231164B2 (en)	2008-05-01
AU2166500A (en)	2000-06-26
ES2401998T3 (es)	2013-04-26
US20050136068A1 (en)	2005-06-23
WO2000034487A1 (en)	2000-06-15
EP1137785B1 (en)	2007-08-15
BRPI9915988B8 (pt)	2021-05-25
SI1892298T1 (sl)	2011-08-31
AU779085B2 (en)	2005-01-06
PT1892298E (pt)	2011-06-01
BR9915988A (pt)	2001-09-04
DK1137785T3 (da)	2007-12-10
MXPA01005757A (es)	2002-04-24
JP2012072153A (ja)	2012-04-12
EP1892298A1 (en)	2008-02-27
CN100389198C (zh)	2008-05-21
EP2308981B1 (en)	2013-02-13
JP2002531584A (ja)	2002-09-24
JP5122703B2 (ja)	2013-01-16
US7635483B2 (en)	2009-12-22
KR20010082326A (ko)	2001-08-29
US8440205B2 (en)	2013-05-14
US20060153879A1 (en)	2006-07-13
ATE370237T1 (de)	2007-09-15
US6951653B2 (en)	2005-10-04
US20040062777A1 (en)	2004-04-01
ES2363446T3 (es)	2011-08-04
AU2004231164A1 (en)	2004-12-09
ATE503017T1 (de)	2011-04-15
EP1137785B8 (en)	2007-11-21
IL143289A (en)	2011-11-30
PT1137785E (pt)	2007-10-22
EP1892298B1 (en)	2011-03-23
DK2308981T3 (da)	2013-05-13
CA2354508A1 (en)	2000-06-15
EP1137785A1 (en)	2001-10-04
DE69936877D1 (de)	2007-09-27
CN1329669A (zh)	2002-01-02
DE69936877T2 (de)	2008-04-30
EP2308981A1 (en)	2011-04-13
IL143289A0 (en)	2002-04-21
KR100777502B1 (ko)	2007-11-16
ES2293745T3 (es)	2008-03-16
BRPI9915988B1 (pt)	2015-08-18
DE69943305D1 (de)	2011-05-05
US6355255B1 (en)	2002-03-12
SI2308981T1 (sl)	2013-04-30
PT2308981E (pt)	2013-02-21
CA2354508C (en)	2011-02-01
CY1106983T1 (el)	2012-09-26
CN1679929B (zh)	2012-09-26

Publication	Publication Date	Title
ATE370237T1 (de)	2007-09-15	Streptokokken-c5a-peptidase-impfstoff
PT877624E (pt)	2004-08-31	Vacina de c5a peptidase estreptococica
DK0625053T3 (da)	2002-08-12	Urease-baseret vaccine mod Helicobacter-infektion
EP0652758A4 (en)	1997-02-12	VACCINES AGAINST DIPHTERY TOXIN.
EP2050464A3 (en)	2012-04-25	Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
DE60045721D1 (de)	2011-04-21	Streptococcus pneumoniae Proteine und Impfstoffe
LU91595I2 (fr)	2009-10-12	Combinaison d'anatoxine diphtérique, d'anatoxine tétanique, d'anatoxine coquelucheuse, d'hémagglutinine filamenteuse, de pertactine et de polyoside capsulaire d'haemophilus influenzae type b (InfanrixHib)
DK0626452T3 (da)	2000-02-14	Vaccine mod infektion af Streptococcus suis
DK0775746T3 (da)	2006-04-03	Vaccine mod fjerkræcoccidiose
DE69510858D1 (de)	1999-08-26	Mukosale Verabreichung von Pneumokokken-Antigenen
ATE283066T1 (de)	2004-12-15	Impfstoff enthaltend zytokin-induzierte heat shock proteine (hsp)
DK0894500T3 (da)	2004-11-15	Streptococcus equi-vaccine
Cleary et al.	2002	Streptococcal C 5 a peptidase vaccine
CA2045950A1 (en)	1992-12-29	Recombinant vaccine for prevention and/or treatment of pleuropneumonia infections
FR2652266B1 (fr)	1994-08-12	Vaccin protecteur contre l'hemophilose porcine.
MX9604262A (es)	1997-12-31	Antigenos de pasteurellaceae y vacunas relacionadas.
MY153646A (en)	2015-03-13	A vaccine protecting against pig haemophilosis.